## **Core Concept**
Severe widespread psoriasis often requires systemic treatment due to the extensive skin involvement. Topical treatments are generally reserved for mild to moderate psoriasis due to their limited efficacy in widespread disease. Systemic treatments can include biologics, traditional systemic agents like methotrexate, cyclosporine, and acitretin.

## **Why the Correct Answer is Right**
Topical corticosteroids (Option C) are generally not recommended for severe widespread psoriasis because their efficacy is limited in extensive disease, and long-term use can lead to significant side effects, including skin atrophy, systemic absorption leading to Cushing's syndrome, and rebound flare-ups upon discontinuation.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option likely represents a biologic agent, which is appropriate for severe widespread psoriasis. Biologics target specific pathways involved in inflammation and are effective in treating severe psoriasis.
- **Option B:** This could represent a traditional systemic agent like methotrexate or cyclosporine, which are used for severe psoriasis. They have broad mechanisms of action that can help control widespread disease.
- **Option D:** This might represent another systemic agent or a light therapy option, both of which can be used for severe psoriasis.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that in severe widespread psoriasis, treatments are often divided into topical (for mild disease), phototherapy (for moderate disease), and systemic therapies (including biologics, for severe disease). The use of topical corticosteroids as a monotherapy in severe widespread psoriasis can lead to more harm than benefit due to potential side effects and limited efficacy.

## **Correct Answer:** . Topical corticosteroids.